• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鉴定人白细胞相关免疫球蛋白样受体LAIR在胶原蛋白II和III上的多个强效结合位点。

Identification of multiple potent binding sites for human leukocyte associated Ig-like receptor LAIR on collagens II and III.

作者信息

Lebbink Robert Jan, Raynal Nicolas, de Ruiter Talitha, Bihan Dominique G, Farndale Richard W, Meyaard Linde

机构信息

Department of Immunology, University Medical Center Utrecht, Utrecht, The Netherlands.

出版信息

Matrix Biol. 2009 May;28(4):202-10. doi: 10.1016/j.matbio.2009.03.005. Epub 2009 Apr 2.

DOI:10.1016/j.matbio.2009.03.005
PMID:19345263
Abstract

Immune responses are tightly controlled by the opposing actions of activating and inhibitory immune receptors. Previously we identified collagens as ligands for the inhibitory leukocyte-associated Ig-like receptor-1 (LAIR-1), revealing a novel mechanism of peripheral immune regulation by inhibitory immune receptors binding to extracellular matrix collagens. This interaction can be blocked by LAIR-2, a secreted member of the LAIR-1 family. LAIR-1 specifically interacts with synthetic trimeric peptides containing 10 repeats of glycine-proline-hydroxyproline (GPO) residues which can directly inhibit immune cell activation in vitro. Here we studied the interaction of human LAIR-1 and LAIR-2 with collagen in more detail by using novel overlapping synthetic trimeric peptides (Toolkits) encompassing the entire triple-helical domain of human collagens II and III. LAIR-1 and LAIR-2 bind several of these collagen-like peptides, with LAIR-2 being able to bind more than LAIR-1. LAIR binding to trimeric collagen peptides was influenced by GPO content of the peptide, although additional non-GPO triplets contributed to the interaction. Furthermore, we identified several trimeric peptides that were potent LAIR-1 ligands and could efficiently induce inhibition of T cell activation and FceRI-induced degranulation of RBL-2H3 cells through binding to LAIR-1. A detailed understanding of the LAIR recognition motifs within collagen may lead to the development of potent reagents that can be used in in vitro, ex vivo, and in vivo functional studies to dissect the biology and function of the collagen/LAIR-1 interaction.

摘要

免疫反应受到激活和抑制性免疫受体相反作用的严格控制。此前我们鉴定出胶原蛋白是抑制性白细胞相关免疫球蛋白样受体-1(LAIR-1)的配体,揭示了抑制性免疫受体与细胞外基质胶原蛋白结合对外周免疫调节的新机制。这种相互作用可被LAIR-1家族的分泌成员LAIR-2阻断。LAIR-1与含有10个甘氨酸-脯氨酸-羟脯氨酸(GPO)残基重复序列的合成三聚体肽特异性相互作用,该肽在体外可直接抑制免疫细胞激活。在此,我们通过使用包含人胶原蛋白II和III整个三螺旋结构域的新型重叠合成三聚体肽(工具包),更详细地研究了人LAIR-1和LAIR-2与胶原蛋白的相互作用。LAIR-1和LAIR-2与其中几种胶原样肽结合,LAIR-2比LAIR-1能结合更多肽。LAIR与三聚体胶原肽的结合受肽的GPO含量影响,尽管其他非GPO三联体也参与了相互作用。此外,我们鉴定出几种三聚体肽是有效的LAIR-1配体,通过与LAIR-1结合可有效诱导T细胞激活抑制以及RBL-2H3细胞的FceRI诱导的脱颗粒。对胶原蛋白内LAIR识别基序的详细了解可能会促成开发有效的试剂,可用于体外、离体和体内功能研究,以剖析胶原蛋白/LAIR-1相互作用的生物学和功能。

相似文献

1
Identification of multiple potent binding sites for human leukocyte associated Ig-like receptor LAIR on collagens II and III.鉴定人白细胞相关免疫球蛋白样受体LAIR在胶原蛋白II和III上的多个强效结合位点。
Matrix Biol. 2009 May;28(4):202-10. doi: 10.1016/j.matbio.2009.03.005. Epub 2009 Apr 2.
2
Collagen binding specificity of the discoidin domain receptors: binding sites on collagens II and III and molecular determinants for collagen IV recognition by DDR1.Discoidin domain receptor 胶原蛋白结合特异性:胶原蛋白 II 和 III 的结合位点以及 DDR1 识别胶原蛋白 IV 的分子决定因素。
Matrix Biol. 2011 Jan;30(1):16-26. doi: 10.1016/j.matbio.2010.10.004. Epub 2010 Oct 28.
3
Collagens are functional, high affinity ligands for the inhibitory immune receptor LAIR-1.胶原蛋白是抑制性免疫受体LAIR-1的功能性高亲和力配体。
J Exp Med. 2006 Jun 12;203(6):1419-25. doi: 10.1084/jem.20052554. Epub 2006 Jun 5.
4
Structural basis for the platelet-collagen interaction: the smallest motif within collagen that recognizes and activates platelet Glycoprotein VI contains two glycine-proline-hydroxyproline triplets.血小板与胶原蛋白相互作用的结构基础:胶原蛋白中识别并激活血小板糖蛋白VI的最小基序包含两个甘氨酸-脯氨酸-羟脯氨酸三联体。
J Biol Chem. 2007 Jan 12;282(2):1296-304. doi: 10.1074/jbc.M606479200. Epub 2006 Nov 2.
5
Crystal structure and collagen-binding site of immune inhibitory receptor LAIR-1: unexpected implications for collagen binding by platelet receptor GPVI.LAIR-1 免疫抑制受体的晶体结构和胶原蛋白结合位点:对血小板受体 GPVI 胶原蛋白结合的意外影响。
Blood. 2010 Feb 18;115(7):1364-73. doi: 10.1182/blood-2009-10-246322. Epub 2009 Dec 10.
6
Cancer immunotherapy by NC410, a LAIR-2 Fc protein blocking human LAIR-collagen interaction.NC410 通过阻断人 LAIR-2 与胶原的相互作用进行癌症免疫治疗。
Elife. 2021 Jun 14;10:e62927. doi: 10.7554/eLife.62927.
7
Collagen Fragments Produced in Cancer Mediate T Cell Suppression Through Leukocyte-Associated Immunoglobulin-Like Receptor 1.胶原蛋白片段在癌症中产生,通过白细胞相关免疫球蛋白样受体 1 介导 T 细胞抑制。
Front Immunol. 2021 Oct 7;12:733561. doi: 10.3389/fimmu.2021.733561. eCollection 2021.
8
Cell-collagen interactions: the use of peptide Toolkits to investigate collagen-receptor interactions.细胞-胶原蛋白相互作用:利用肽类工具包研究胶原蛋白-受体相互作用。
Biochem Soc Trans. 2008 Apr;36(Pt 2):241-50. doi: 10.1042/BST0360241.
9
Efficient inhibition of collagen-induced platelet activation and adhesion by LAIR-2, a soluble Ig-like receptor family member.LAIR-2,一种可溶性免疫球蛋白样受体家族成员,可有效抑制胶原诱导的血小板活化和黏附。
PLoS One. 2010 Aug 13;5(8):e12174. doi: 10.1371/journal.pone.0012174.
10
Tumor-expressed collagens can modulate immune cell function through the inhibitory collagen receptor LAIR-1.肿瘤表达的胶原可以通过抑制性胶原受体 LAIR-1 调节免疫细胞功能。
Mol Immunol. 2011 Oct;49(1-2):402-6. doi: 10.1016/j.molimm.2011.09.006. Epub 2011 Sep 28.

引用本文的文献

1
The Role of LAIR1 as a Regulatory Receptor of Antitumor Immune Cell Responses and Tumor Cell Growth and Expansion.LAIR1作为抗肿瘤免疫细胞反应以及肿瘤细胞生长与增殖的调节性受体的作用。
Biomolecules. 2025 Jun 13;15(6):866. doi: 10.3390/biom15060866.
2
Inhibitory pattern recognition receptors: lessons from LAIR1.抑制性模式识别受体:来自LAIR1的经验教训。
Nat Rev Immunol. 2025 May 27. doi: 10.1038/s41577-025-01181-2.
3
Distinct Immunological Features Compared to Lichen Planus and Oral Lichen Planus.与扁平苔藓和口腔扁平苔藓相比的独特免疫特征。
J Inflamm Res. 2025 Mar 18;18:4037-4056. doi: 10.2147/JIR.S506313. eCollection 2025.
4
Leukocyte-associated immunoglobulin-like receptor-1 blockade in combination with programmed death-ligand 1 targeting therapy mediates increased tumour control in mice.白细胞相关免疫球蛋白样受体-1阻断与程序性死亡配体1靶向治疗联合可增强对小鼠肿瘤的控制。
Cancer Immunol Immunother. 2024 Jan 18;73(1):16. doi: 10.1007/s00262-023-03600-6.
5
Construction of an immune-related risk score signature for gastric cancer based on multi-omics data.基于多组学数据构建胃癌免疫相关风险评分特征。
Sci Rep. 2024 Jan 16;14(1):1422. doi: 10.1038/s41598-024-52087-3.
6
The extracellular matrix in hepatocellular carcinoma: Mechanisms and therapeutic vulnerability.肝细胞癌中的细胞外基质:机制与治疗弱点。
Cell Rep Med. 2023 Sep 19;4(9):101170. doi: 10.1016/j.xcrm.2023.101170. Epub 2023 Aug 30.
7
A recombinant technique for mapping functional sites of heterotrimeric collagen helices: Collagen IV CB3 fragment as a prototype for integrin binding.一种用于定位异三聚体胶原蛋白螺旋功能位点的重组技术:以胶原蛋白 IV CB3 片段作为整合素结合的原型。
J Biol Chem. 2023 Jul;299(7):104901. doi: 10.1016/j.jbc.2023.104901. Epub 2023 Jun 10.
8
Recombinant humanized collagen remodels endometrial immune microenvironment of chronic endometritis through macrophage immunomodulation.重组人源化胶原蛋白通过巨噬细胞免疫调节重塑慢性子宫内膜炎的子宫内膜免疫微环境。
Regen Biomater. 2023 Apr 3;10:rbad033. doi: 10.1093/rb/rbad033. eCollection 2023.
9
Shaping the Future of Immunotherapy Targets and Biomarkers in Melanoma and Non-Melanoma Cutaneous Cancers.塑造黑色素瘤和非黑色素瘤皮肤癌免疫治疗靶点和生物标志物的未来。
Int J Mol Sci. 2023 Jan 9;24(2):1294. doi: 10.3390/ijms24021294.
10
Association of LncRNA-PAX8-AS1 and LAIR-2 polymorphisms along with their expression with clinical and subclinical hypothyroidism.LncRNA-PAX8-AS1 和 LAIR-2 多态性及其表达与临床和亚临床甲状腺功能减退症的关联。
Sci Rep. 2023 Jan 2;13(1):6. doi: 10.1038/s41598-022-26346-0.